Table 3.
Outcome | HR | 95% CI | P Value |
---|---|---|---|
Incident MI | |||
All participants (N=991) | 2.68 | 1.86–3.85 | <0.001 |
Obstructive CAD (n=619) | 1.87 | 1.16–3.00 | 0.01 |
Nonobstructive CAD (N=226) | 8.41 | 2.77–25.5 | <0.001 |
Incident HF | |||
All participants (N=991) | 1.60 | 1.21–2.13 | 0.001 |
Obstructive CAD (n=619) | 1.17 | 0.76–1.80 | 0.46 |
Nonobstructive CAD (n=226) | 1.61 | 0.85–3.06 | 0.14 |
Cardiovascular death | |||
All participants (N=991) | 2.29 | 1.40–3.75 | 0.001 |
Obstructive CAD (n=619) | 2.74 | 1.48–5.06 | 0.001 |
Nonobstructive CAD (n=226) | 3.60 | 1.15–11.3 | 0.03 |
All‐cause death | |||
All participants (N=991) | 1.84 | 1.22–2.78 | 0.004 |
Obstructive CAD (n=619) | 2.06 | 1.26–3.37 | 0.004 |
Nonobstructive CAD (n=226) | 2.25 | 0.83–6.12 | 0.11 |
Incident MI/HF/all‐cause death | |||
All participants (N=991) | 1.62 | 1.26–2.08 | <0.001 |
Obstructive CAD (n=619) | 1.71 | 1.25–2.33 | <0.001 |
Nonobstructive CAD (n=226) | 1.60 | 0.88–2.90 | 0.12 |
Incident MI/cardiovascular death | |||
All participants (N=991) | 2.22 | 1.60–3.08 | <0.001 |
Obstructive CAD (n=619) | 2.06 | 1.40–3.05 | <0.001 |
Nonobstructive CAD (n=226) | 4.70 | 2.17–10.18 | <0.001 |
Incident MI/all‐cause death | |||
All participants (N=991) | 2.13 | 1.56–2.90 | <0.001 |
Obstructive CAD (n=619) | 2.06 | 1.42–2.98 | <0.001 |
Nonobstructive CAD (n=226) | 3.62 | 1.78–7.37 | <0.001 |
CAD indicates coronary artery disease; CI, confidence interval; HF, heart failure; HR, hazard ratio; hsTnI, high‐sensitivity troponin I; MI, myocardial infarction.